CoChat

Identification of Antihypertensive Drugs Which Inhibit Amyloid-β Protein Oligomerization

Zhao, Wei, Wang, Jun, Ho, Lap, Ono, Kenjiro, Teplow, David B., Pasinetti, Giulio M. · 2009 · Journal of Alzheimer's Disease
Cited by 75

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Recent studies suggest that certain cardiovascular antihypertensive agents decrease the incidence of Alzheimer's disease. Based on this evidence and the fact that Abeta aggregation into high-molecular-weight-soluble oligomeric Abeta species is known to directly induce cognitive impairment, we tested the possibility that certain antihypertensive compounds may affect the progression of Alzheimer's disease, at least in part by influencing the formation of Abeta oligomers. High throughput screening of 55 commercially available antihypertensive drugs identified four compounds that significantly reduced Abeta(1-42) oligomerization in a dose dependent manner. These four compounds, furosemide (diuretic), nitrendipine (calcium channel blocker), candesartan cilextil (angiotensin II receptor antagonist) and diazoxide (vasodilator) showed no detectable Abeta lowering activities in primary neuron cultures generated from Tg2576 mouse embryos. However, furosemide, nitrendipine and candesartan cilextil prevented oligomerization of both Abeta(1-40) and Abeta(1-42) in vitro. Furosemide also dissociated pre-aggregated Abeta(1-42) oligomers. Furthermore, short term furosemide treatment resulted in decreased amount of Abeta oligomers in the brain of Tg2576 mice. Our studies suggest that certain antihypertensive compounds may prevent AD-type neuropathology through inhibition of Abeta oligomer formation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-2009-0925

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 6 references

Cited by

See all 75

Metadata

Authors
Zhao, W., Wang, J., Ho, L., Ono, K., Teplow, D. B., & Pasinetti, G. M.
Venue
Journal of Alzheimer's Disease
Published
2009-01-04
Volume
16
Issue
1
Pages
49-57
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W1417309998
Cited by
75
References
6
FWCI
3.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of Antihypertensive Drugs Which Inhibit Amyloid-β Protein Oligomerization. https://app.cochat.ai/papers/10.3233/jad-2009-0925
The paper
Zhao, W., Wang, J., Ho, L., Ono, K., Teplow, D. B., & Pasinetti, G. M. (2009). Identification of Antihypertensive Drugs Which Inhibit Amyloid-β Protein Oligomerization. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-2009-0925

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.